Finance

Lists
3NK:FRA
Alphamab Oncology
€0,92
-1,61%
(-0,015) 1D
2 Okt., 22:00:00 GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 3NK...
Open
€0,92
High
€0,92
Low
€0,92
Mkt. cap
8,03 mjd
Avg. vol.
0,00
Volume
0,00
52-wk high
€1,68
52-wk low
€0,70
No. of employees
515
Open
€0,92
High
€0,92
Low
€0,92
Mkt. cap
8,03 mjd
Avg. vol.
0,00
Volume
0,00
52-wk high
€1,68
52-wk low
€0,70
No. of employees
515
News stories
From web sources and news partners
About Alphamab Oncology
CEOTing Xu
Employees515
Founded2008
Headquarters-
Sector-
Websitealphamabonc.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
123,40 m
123,40 m
135,62 m
135,62 m
Cost of goods sold
16,14 m
16,14 m
13,16 m
13,16 m
Cost of revenue
16,14 m
16,14 m
13,16 m
13,16 m
Research and development expenses
159,43 m
159,43 m
127,48 m
127,48 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
24,79 m
24,79 m
17,06 m
17,06 m
Operating expense
184,22 m
184,22 m
144,54 m
144,54 m
Total operating expenses
200,37 m
200,37 m
157,70 m
157,70 m
Operating income
-76,97 m
-76,97 m
-22,08 m
-22,08 m
Other non operating income
5,05 m
5,05 m
155,50 k
155,50 k
EBT including unusual items
-67,76 m
-67,76 m
-20,23 m
-20,23 m
EBT excluding unusual items
-67,76 m
-67,76 m
-20,23 m
-20,23 m
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-67,76 m
-67,76 m
-20,23 m
-20,23 m
Net profit margin
-54,91%
-54,91%
-14,92%
-14,92%
Earnings per share
-
-
-
-
Interest and investment income
7,75 m
7,75 m
6,09 m
6,09 m
Interest expense
-1,75 m
-1,75 m
-1,47 m
-1,47 m
Net interest expenses
6,00 m
6,00 m
4,62 m
4,62 m
Depreciation and amortization charges
-
-
-
-
EBITDA
-61,19 m
-61,19 m
-6,52 m
-6,52 m
Gain or loss from assets sale
1,00 k
1,00 k
11,00 k
11,00 k
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme